Phase 1 Microbiome Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
Colorectal, CancerStenosisFibrosis, Liver+4 more
Massachusetts General Hospital80 enrolled1 locationNCT05692024
Recruiting
Phase 1Phase 2
Curcumin and Retinal Study
SafetyGut MicrobiomeBioavailability
Texas Tech University Health Sciences Center60 enrolled1 locationNCT05774704
Recruiting
Phase 1Phase 2
Oral Changes With Caloric and no Caloric Sweeteners
MicrobiomepHDental Plaque
Hospital Infantil de Mexico Federico Gomez52 enrolled1 locationNCT05852145
Recruiting
Phase 1Phase 2
Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.
Intestinal microbiomeMicrobiotaGastrointestinal Microbiome+3 more
National Institute of Allergy and Infectious Diseases (NIAID)600 enrolled1 locationNCT03298334
Recruiting
Phase 1Phase 2
Microbial Restoration in Inflammatory Bowel Diseases
Inflammatory Bowel DiseasesCrohn DiseaseMicrobiome+1 more
St Vincent's Hospital Melbourne120 enrolled1 locationNCT04970446
Recruiting
Phase 1
Metabolic and Metagenomic Effects of Intestinal Microbiome Repopulation in Unexplained Atherosclerosis
Intestinal microbiomeAtherosclerosis
Western University, Canada100 enrolled1 locationNCT04410003